0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Structural Heart Devices Market Forecast up to 2024
Published Date: February 2019
|
Report Code: INFO-Othe-12
Home | Category |Health |Health Conditions |Heart & Hypertension
Global Structural Heart Devices Market Forecast up to 2024

Global Structural Heart Devices Market Forecast up to 2024

Code: INFO-Othe-12
Report
February 2019
97 Pages
Infoholic Research
Region: Global,
Description
Table of Content
Tables & Figures

Global Structural Heart Devices Market – Drivers, Restraints, Opportunities, Trends, and Forecast: 2018–2024


Overview: Structural heart disease are the abnormalities in the heart by birth or which develop later in life because of aging, infections, or injury, which leads to heart attacks and other underlying ailments. The term structural heart disease involves a range of ailments linked with congestive heart failure (CHF) and embolic stroke, together with atrial septal defect (ASD), ventricular septal defect (VSD), patent foramen ovale (PFO) and left atrial appendix (LAA).


Increasing aging population, increasing prevalence of cardiovascular diseases, and increase in minimally invasive surgery for structural heart diseases are the factors aiding for the growth of the structural heart devices market. Increase healthcare spending, increase in the number of outpatient procedures, and market expansion opportunities in emerging nations are providing an opportunity for the market growth. However, lack of skilled healthcare professionals and stringent regulatory approval process are hampering the market growth.


Market Analysis: The “Global Structural Heart Devices Market” is estimated to witness a CAGR of 10.2% during the forecast period 2018–2024. The structural heart devices market is analyzed based on three segments – Type, End Users, and Regions.


Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the structural heart devices market, followed by Europe, Asia Pacific, and Rest of the World. More than 40% of the market is occupied by North America, with the US being the major contributor to the market growth in 2017.


Type Analysis: Based on the type, the market is segmented into structural heart repair devices and structural heart replacement devices. The major share holder of the market are structural heart replacement devices and is also the fastest growing segment in the market.


End Users Analysis: Based on the end users, the market is segmented into hospitals, ambulatory surgical centers, and cardiac centers. The hospitals are the largest among end-users and are preferred for the treatment due to the advantages such as availability of surgery specialists, reimbursement facility, and availability of high end equipment for the surgery.


Key Players: The major players in the market are Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Edward LifeSciences Corp., and LivaNova PLC. Lepu Medical Technology, CryoLife, Inc., JenaValve Technologies GmbH, TTK Healthcare, and Braile Biomédica, are the key other key players in the market.


Competitive Analysis: Mergers and acquisitions has been the major strategy followed by major players in the market to maintain their leadership in the market. Edwards congealed its position in the mitral valve market by buying the Harpoon Medical, the DMR-focused chordal surgical mitral valve repair startup company for ~$100M upfront. Many players in the market are flooding into the TMVR arena, the market can expect strong and innovative state-of-the-art technologies, creating intense competition in the future. A Canadian company, NeoVasc has developed a novel technology device named Tiara to replace any regurgitation of mitral valves. However, these devices have not gained approval yet and as such are lagging far behind the MitraClip. As a result, Abbott Vascular will have many years to solidify its place as the market leader in TMVR solutions.


Benefits: The report provides complete details about the usage and adoption rate of structural heart devices in various regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.

Table of Contents

1 Industry Outlook 8
1.1 Industry Overview 8
1.2 Total Addressable Market 9
2 Report Outline 12
2.1 Report Scope 12
2.2 Report Summary 12
2.3 Research Methodology 13
2.4 Report Assumptions 14
3 Market Snapshot 15
3.1 Market Definition – Infoholic Research 15
3.2 Segmented Addressable Market (SAM) 15
3.2.1 Symptoms of Structural Heart Disease 15
3.3 Industry Trends 16
3.4 Related Markets 16
3.4.1 Cardiovascular Drugs 16
3.4.1.1 Trends of the cardiovascular drugs market 17
3.4.2 Cardiovascular Diagnostics 17
3.4.3 Prosthetic Heart Valves 18
4 Market Outlook 20
4.1 Reimbursement 20
4.2 Porter 5 (Five) Forces 23
5 Market Characteristics 25
5.1 Evolution 25
5.2 Market Segmentation 25
5.3 Market Dynamics 26
5.3.1 Drivers 26
5.3.1.1 Increase in minimally invasive surgery for structural heart diseases 26
5.3.1.2 Increasing prevalence of cardiovascular diseases 27
5.3.1.3 Increasing aging population 27
5.3.2 Restraints 28
5.3.2.1 Stringent regulatory approval process 28
5.3.2.2 Lack of skilled healthcare professionals 28
5.3.3 Opportunities 28
5.3.3.1 Increase in healthcare spending 28
5.3.3.2 Increase in the number of outpatient procedures 29
5.3.3.3 Market expansion opportunities in emerging nations 29
5.3.4 DRO – Impact Analysis 30
5.4 Key Stakeholders 31
6 Types: Market Size and Analysis 32
6.1 Overview 32
6.2 Structural Heart Repair Devices 33
6.2.1 Surgical Heart Repair Devices 35
6.2.2 Transcatheter Heart Repair Devices 35
6.3 Structural Heart Replacement Devices 37
6.3.1 Surgical Heart Replacement Devices 38
6.3.2 Transcatheter Heart Replacement Devices 40
7 End Users: Market Size and Analysis 44
7.1 Overview 44
7.2 Hospitals 44
7.3 Ambulatory Surgical Center 45
7.4 Cardiac Centers 46
8 Regions: Market Size and Analysis 47
8.1 Overview 47
8.2 North America 48
8.2.1 Overview 48
8.3 Europe 50
8.3.1 Overview 50
8.4 Asia Pacific 51
8.4.1 Overview 51
8.5 Rest of the World 53
8.5.1 Overview 53
9 Competitive Landscape 56
10 Vendors Profile 58
10.1 Abbott Laboratories 58
10.1.1 Overview 58
10.1.2 Business Units 60
10.1.3 Geographic Presence 62
10.1.4 Business Focus 62
10.1.5 SWOT Analysis 63
10.1.6 Business Strategies 63
10.2 Boston Scientific Corp. 64
10.2.1 Overview 64
10.2.2 Business Units 66
10.2.3 Geographic Presence 67
10.2.4 Business Focus 67
10.2.5 SWOT Analysis 68
10.2.6 Business Strategies 68
10.3 Medtronic plc 69
10.3.1 Overview 69
10.3.2 Business Units 78
10.3.3 Geographic Presence 79
10.3.4 Business Focus 79
10.3.5 SWOT Analysis 80
10.3.6 Business Strategies 80
10.4 Edwards Lifesciences Corp. 81
10.4.1 Overview 81
10.4.2 Business Units 83
10.4.3 Geographic Presence 84
10.4.4 Business Focus 84
10.4.5 SWOT Analysis 85
10.4.6 Business Strategies 85
10.5 LivaNova, PLC 86
10.5.1 Overview 86
10.5.2 Business Units 88
10.5.3 Geographic Presence 89
10.5.4 Business Focus 89
10.5.5 SWOT Analysis 90
10.5.6 Business Strategies 90
11 Companies to Watch for 91
11.1 Lepu Medical Technology Co., Ltd. 91
11.1.1 Overview 91
11.1.2 Key Highlights 92
11.2 CryoLife, Inc 92
11.2.1 Overview 92
11.2.2 Key Highlights 93
11.3 JenaValve Technology GmbH 93
11.3.1 Overview 93
11.3.2 Key Highlights 94
11.4 TTK Healthcare Ltd. 94
11.4.1 Overview 94
11.4.2 Key Highlights 95
11.5 Braile Biomédica 95
11.5.1 Overview 95
Annexure 96
Ø Acronyms 96

List of Tables

TABLE 1 TOP ACQUISITIONS IN CARDIOVASCULAR INDUSTRY 11
TABLE 2 STRUCTURAL HEART DEVICES MARKET REVENUE, BY TYPE, 2017–2024 ($MILLION) 32
TABLE 3 ANNULOPLASTY RINGS AVERAGE PRICES 35
TABLE 4 HEART VALVE, MECHANICAL AVERAGE SELLING PRICE 39
TABLE 5 HEART VALVE AVERAGE PRICES 41
TABLE 6 ABBOTT LABORATORIES: PRODUCT OFFERINGS 58
TABLE 7 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 58
TABLE 8 BOSTON SCIENTIFIC CORP.: OFFERINGS 64
TABLE 9 BOSTON SCIENTIFIC CORP: RECENT DEVELOPMENTS 64
TABLE 10 MEDTRONIC PLC: OFFERINGS 69
TABLE 11 MEDTRONIC PLC: RECENT DEVELOPMENTS 69
TABLE 12 EDWARD LIFESCIENCES CORP.: OFFERINGS 81
TABLE 13 EDWARD LIFESCIENCES CORP.: RECENT DEVELOPMENTS 81
TABLE 14 LIVANOVA PLC: OFFERINGS 86
TABLE 15 LIVANOVA PLC: RECENT DEVELOPMENTS 86
TABLE 16 LEPU MEDICAL TECHNOLOGY CO., LTD.: OVERVIEW 91
TABLE 17 LEPU MEDICAL TECHNOLOGY CO., LTD.: RECENT DEVELOPMENTS 91
TABLE 18 CRYOLIFE, INC.: OVERVIEW 92
TABLE 19 CRYOLIFE, INC.: RECENT DEVELOPMENTS 92
TABLE 20 JENAVALVE TECHNOLOGY GMBH.: OVERVIEW 93
TABLE 21 JENAVALVE TECHNOLOGY GMBH.: RECENT DEVELOPMENTS 93
TABLE 22 TTK HEALTHCARE LTD.: OVERVIEW 94
TABLE 23 TTK HEALTHCARE LTD.: RECENT DEVELOPMENTS 94
TABLE 24 BRAILE BIOMÉDICA.: OVERVIEW 95
TABLE 25 BRAILE BIOMÉDICA.: RECENT DEVELOPMENTS 95

List of Charts

CHART 1 GLOBAL CARDIOVASCULAR DISEASES MARKET REVENUE, 2017 ($BILLION) 10
CHART 2 RESEARCH METHODOLOGY OF GLOBAL STRUCTURAL HEART DEVICES MARKET 14
CHART 3 STRUCTURAL HEART DEVICES MARKET REVENUE, 2017-2024 ($MILLION) 16
CHART 4 PORTERS 5 FORCES ON STRUCTURAL HEART DEVICES MARKET 23
CHART 6 STRUCTURAL HEART DEVICES MARKET SEGMENTATION 25
CHART 7 MARKET DYNAMICS – DRIVERS, RESTRAINTS & OPPORTUNITIES 26
CHART 8 DRO - IMPACT ANALYSIS OF STRUCTURAL HEART DEVICES MARKET 30
CHART 9 KEY STAKEHOLDERS OF STRUCTURAL HEART DEVICES MARKET 31
CHART 10 STRUCTURAL HEART DEVICES MARKET SEGMENT REVENUE BY TYPE, 2017 VS 2024 ($ MILLION) 32
CHART 11 STRUCTURAL HEART REPAIR DEVICES MARKET REVENUE, BY TYPES 2017-2024 ($MILLION) 33
CHART 12 STRUCTURAL HEART REPAIR DEVICES MARKET REVENUE, BY TYPES 2017 ($MILLION) 34
CHART 13 STRUCTURAL HEART REPLACEMENT DEVICE MARKET REVENUE, BY TYPE 2017-2024 ($MILLION) 37
CHART 14 STRUCTURAL HEART REPLACEMENT DEVICES MARKET REVENUE, BY TYPES 2017-2024 ($MILLION) 37
CHART 15 SURGICAL HEART REPLACEMENT DEVICES MARKET REVENUE, BY TYPES 2017 (%) 39
TRANSCATHETER VALVES 41
CHART 16 TRANSCATHETER VALVE REPLACEMENT DEVICES MARKET REVENUE, BY TYPES 2017 ($MILLION) 42
CHART 17 STRUCTURAL HEART DEVICES MARKET SEGMENT REVENUE BY END USERS, 2017 (%) 44
CHART 18 STRUCTURAL HEART DEVICES MARKET BY REGIONAL SEGMENTATION, 2017 (%) 48
CHART 19 STRUCTURAL HEART DEVICES MARKET REVENUE IN NORTH AMERICA, 2017-2024 ($MILLION) 49
CHART 20 STRUCTURAL HEART DEVICES MARKET REVENUE IN EUROPE, 2017-2024 ($MILLION) 50
CHART 21 STRUCTURAL HEART DEVICES MARKET REVENUE IN ASIA PACIFIC, 2017-2024 ($MILLION) 53
CHART 22 STRUCTURAL HEART DEVICES REVENUE IN REST OF THE WORLD, 2017-2024 ($MILLION) 55
CHART 23 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT 59
CHART 24 ABBOTT LABORATORIES: BUSINESS UNITS 60
CHART 25 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 61
CHART 26 ABBOTT LABORATORIES: SWOT ANALYSIS 63
CHART 27 BOSTON SCIENTIFIC CORP.: OVERVIEW SNAPSHOT 65
CHART 28 BOSTON SCIENTIFIC CORP.: BUSINESS UNITS 66
CHART 29 BOSTON SCIENTIFIC CORP.: GEOGRAPHIC PRESENCE 67
CHART 30 BOSTON SCIENTIFIC CORP.: SWOT ANALYSIS 68
CHART 31 MEDTRONIC PLC: OVERVIEW SNAPSHOT 76
CHART 32 MEDTRONIC PLC: BUSINESS UNITS 78
CHART 33 MEDTRONIC PLC: GEOGRAPHIC PRESENCE 79
CHART 34 MEDTRONIC PLC: SWOT ANALYSIS 80
CHART 35 EDWARD LIFESCIENCES CORP: OVERVIEW SNAPSHOT 82
CHART 36 EDWARD LIFESCIENCES CORP: BUSINESS UNITS 83
CHART 37 EDWARD LIFESCIENCES CORP: GEOGRAPHIC PRESENCE 84
CHART 38 EDWARD LIFESCIENCES CORP: SWOT ANALYSIS 85
CHART 39 LIVANOVA: OVERVIEW SNAPSHOT 87
CHART 40 LIVANOVA PLC: BUSINESS UNITS 88
CHART 41 LIVANOVA PLC: GEOGRAPHIC PRESENCE 89
CHART 42 LIVANOVA PLC: SWOT ANALYSIS 90

Global Structural Heart Devices Market – Drivers, Restraints, Opportunities, Trends, and Forecast: 2018–2024


Overview: Structural heart disease are the abnormalities in the heart by birth or which develop later in life because of aging, infections, or injury, which leads to heart attacks and other underlying ailments. The term structural heart disease involves a range of ailments linked with congestive heart failure (CHF) and embolic stroke, together with atrial septal defect (ASD), ventricular septal defect (VSD), patent foramen ovale (PFO) and left atrial appendix (LAA).


Increasing aging population, increasing prevalence of cardiovascular diseases, and increase in minimally invasive surgery for structural heart diseases are the factors aiding for the growth of the structural heart devices market. Increase healthcare spending, increase in the number of outpatient procedures, and market expansion opportunities in emerging nations are providing an opportunity for the market growth. However, lack of skilled healthcare professionals and stringent regulatory approval process are hampering the market growth.


Market Analysis: The “Global Structural Heart Devices Market” is estimated to witness a CAGR of 10.2% during the forecast period 2018–2024. The structural heart devices market is analyzed based on three segments – Type, End Users, and Regions.


Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the structural heart devices market, followed by Europe, Asia Pacific, and Rest of the World. More than 40% of the market is occupied by North America, with the US being the major contributor to the market growth in 2017.


Type Analysis: Based on the type, the market is segmented into structural heart repair devices and structural heart replacement devices. The major share holder of the market are structural heart replacement devices and is also the fastest growing segment in the market.


End Users Analysis: Based on the end users, the market is segmented into hospitals, ambulatory surgical centers, and cardiac centers. The hospitals are the largest among end-users and are preferred for the treatment due to the advantages such as availability of surgery specialists, reimbursement facility, and availability of high end equipment for the surgery.


Key Players: The major players in the market are Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Edward LifeSciences Corp., and LivaNova PLC. Lepu Medical Technology, CryoLife, Inc., JenaValve Technologies GmbH, TTK Healthcare, and Braile Biomédica, are the key other key players in the market.


Competitive Analysis: Mergers and acquisitions has been the major strategy followed by major players in the market to maintain their leadership in the market. Edwards congealed its position in the mitral valve market by buying the Harpoon Medical, the DMR-focused chordal surgical mitral valve repair startup company for ~$100M upfront. Many players in the market are flooding into the TMVR arena, the market can expect strong and innovative state-of-the-art technologies, creating intense competition in the future. A Canadian company, NeoVasc has developed a novel technology device named Tiara to replace any regurgitation of mitral valves. However, these devices have not gained approval yet and as such are lagging far behind the MitraClip. As a result, Abbott Vascular will have many years to solidify its place as the market leader in TMVR solutions.


Benefits: The report provides complete details about the usage and adoption rate of structural heart devices in various regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.

Read More

Table of Contents

1 Industry Outlook 8
1.1 Industry Overview 8
1.2 Total Addressable Market 9
2 Report Outline 12
2.1 Report Scope 12
2.2 Report Summary 12
2.3 Research Methodology 13
2.4 Report Assumptions 14
3 Market Snapshot 15
3.1 Market Definition – Infoholic Research 15
3.2 Segmented Addressable Market (SAM) 15
3.2.1 Symptoms of Structural Heart Disease 15
3.3 Industry Trends 16
3.4 Related Markets 16
3.4.1 Cardiovascular Drugs 16
3.4.1.1 Trends of the cardiovascular drugs market 17
3.4.2 Cardiovascular Diagnostics 17
3.4.3 Prosthetic Heart Valves 18
4 Market Outlook 20
4.1 Reimbursement 20
4.2 Porter 5 (Five) Forces 23
5 Market Characteristics 25
5.1 Evolution 25
5.2 Market Segmentation 25
5.3 Market Dynamics 26
5.3.1 Drivers 26
5.3.1.1 Increase in minimally invasive surgery for structural heart diseases 26
5.3.1.2 Increasing prevalence of cardiovascular diseases 27
5.3.1.3 Increasing aging population 27
5.3.2 Restraints 28
5.3.2.1 Stringent regulatory approval process 28
5.3.2.2 Lack of skilled healthcare professionals 28
5.3.3 Opportunities 28
5.3.3.1 Increase in healthcare spending 28
5.3.3.2 Increase in the number of outpatient procedures 29
5.3.3.3 Market expansion opportunities in emerging nations 29
5.3.4 DRO – Impact Analysis 30
5.4 Key Stakeholders 31
6 Types: Market Size and Analysis 32
6.1 Overview 32
6.2 Structural Heart Repair Devices 33
6.2.1 Surgical Heart Repair Devices 35
6.2.2 Transcatheter Heart Repair Devices 35
6.3 Structural Heart Replacement Devices 37
6.3.1 Surgical Heart Replacement Devices 38
6.3.2 Transcatheter Heart Replacement Devices 40
7 End Users: Market Size and Analysis 44
7.1 Overview 44
7.2 Hospitals 44
7.3 Ambulatory Surgical Center 45
7.4 Cardiac Centers 46
8 Regions: Market Size and Analysis 47
8.1 Overview 47
8.2 North America 48
8.2.1 Overview 48
8.3 Europe 50
8.3.1 Overview 50
8.4 Asia Pacific 51
8.4.1 Overview 51
8.5 Rest of the World 53
8.5.1 Overview 53
9 Competitive Landscape 56
10 Vendors Profile 58
10.1 Abbott Laboratories 58
10.1.1 Overview 58
10.1.2 Business Units 60
10.1.3 Geographic Presence 62
10.1.4 Business Focus 62
10.1.5 SWOT Analysis 63
10.1.6 Business Strategies 63
10.2 Boston Scientific Corp. 64
10.2.1 Overview 64
10.2.2 Business Units 66
10.2.3 Geographic Presence 67
10.2.4 Business Focus 67
10.2.5 SWOT Analysis 68
10.2.6 Business Strategies 68
10.3 Medtronic plc 69
10.3.1 Overview 69
10.3.2 Business Units 78
10.3.3 Geographic Presence 79
10.3.4 Business Focus 79
10.3.5 SWOT Analysis 80
10.3.6 Business Strategies 80
10.4 Edwards Lifesciences Corp. 81
10.4.1 Overview 81
10.4.2 Business Units 83
10.4.3 Geographic Presence 84
10.4.4 Business Focus 84
10.4.5 SWOT Analysis 85
10.4.6 Business Strategies 85
10.5 LivaNova, PLC 86
10.5.1 Overview 86
10.5.2 Business Units 88
10.5.3 Geographic Presence 89
10.5.4 Business Focus 89
10.5.5 SWOT Analysis 90
10.5.6 Business Strategies 90
11 Companies to Watch for 91
11.1 Lepu Medical Technology Co., Ltd. 91
11.1.1 Overview 91
11.1.2 Key Highlights 92
11.2 CryoLife, Inc 92
11.2.1 Overview 92
11.2.2 Key Highlights 93
11.3 JenaValve Technology GmbH 93
11.3.1 Overview 93
11.3.2 Key Highlights 94
11.4 TTK Healthcare Ltd. 94
11.4.1 Overview 94
11.4.2 Key Highlights 95
11.5 Braile Biomédica 95
11.5.1 Overview 95
Annexure 96
Ø Acronyms 96

Read More

List of Tables

TABLE 1 TOP ACQUISITIONS IN CARDIOVASCULAR INDUSTRY 11
TABLE 2 STRUCTURAL HEART DEVICES MARKET REVENUE, BY TYPE, 2017–2024 ($MILLION) 32
TABLE 3 ANNULOPLASTY RINGS AVERAGE PRICES 35
TABLE 4 HEART VALVE, MECHANICAL AVERAGE SELLING PRICE 39
TABLE 5 HEART VALVE AVERAGE PRICES 41
TABLE 6 ABBOTT LABORATORIES: PRODUCT OFFERINGS 58
TABLE 7 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 58
TABLE 8 BOSTON SCIENTIFIC CORP.: OFFERINGS 64
TABLE 9 BOSTON SCIENTIFIC CORP: RECENT DEVELOPMENTS 64
TABLE 10 MEDTRONIC PLC: OFFERINGS 69
TABLE 11 MEDTRONIC PLC: RECENT DEVELOPMENTS 69
TABLE 12 EDWARD LIFESCIENCES CORP.: OFFERINGS 81
TABLE 13 EDWARD LIFESCIENCES CORP.: RECENT DEVELOPMENTS 81
TABLE 14 LIVANOVA PLC: OFFERINGS 86
TABLE 15 LIVANOVA PLC: RECENT DEVELOPMENTS 86
TABLE 16 LEPU MEDICAL TECHNOLOGY CO., LTD.: OVERVIEW 91
TABLE 17 LEPU MEDICAL TECHNOLOGY CO., LTD.: RECENT DEVELOPMENTS 91
TABLE 18 CRYOLIFE, INC.: OVERVIEW 92
TABLE 19 CRYOLIFE, INC.: RECENT DEVELOPMENTS 92
TABLE 20 JENAVALVE TECHNOLOGY GMBH.: OVERVIEW 93
TABLE 21 JENAVALVE TECHNOLOGY GMBH.: RECENT DEVELOPMENTS 93
TABLE 22 TTK HEALTHCARE LTD.: OVERVIEW 94
TABLE 23 TTK HEALTHCARE LTD.: RECENT DEVELOPMENTS 94
TABLE 24 BRAILE BIOMÉDICA.: OVERVIEW 95
TABLE 25 BRAILE BIOMÉDICA.: RECENT DEVELOPMENTS 95

List of Charts

CHART 1 GLOBAL CARDIOVASCULAR DISEASES MARKET REVENUE, 2017 ($BILLION) 10
CHART 2 RESEARCH METHODOLOGY OF GLOBAL STRUCTURAL HEART DEVICES MARKET 14
CHART 3 STRUCTURAL HEART DEVICES MARKET REVENUE, 2017-2024 ($MILLION) 16
CHART 4 PORTERS 5 FORCES ON STRUCTURAL HEART DEVICES MARKET 23
CHART 6 STRUCTURAL HEART DEVICES MARKET SEGMENTATION 25
CHART 7 MARKET DYNAMICS – DRIVERS, RESTRAINTS & OPPORTUNITIES 26
CHART 8 DRO - IMPACT ANALYSIS OF STRUCTURAL HEART DEVICES MARKET 30
CHART 9 KEY STAKEHOLDERS OF STRUCTURAL HEART DEVICES MARKET 31
CHART 10 STRUCTURAL HEART DEVICES MARKET SEGMENT REVENUE BY TYPE, 2017 VS 2024 ($ MILLION) 32
CHART 11 STRUCTURAL HEART REPAIR DEVICES MARKET REVENUE, BY TYPES 2017-2024 ($MILLION) 33
CHART 12 STRUCTURAL HEART REPAIR DEVICES MARKET REVENUE, BY TYPES 2017 ($MILLION) 34
CHART 13 STRUCTURAL HEART REPLACEMENT DEVICE MARKET REVENUE, BY TYPE 2017-2024 ($MILLION) 37
CHART 14 STRUCTURAL HEART REPLACEMENT DEVICES MARKET REVENUE, BY TYPES 2017-2024 ($MILLION) 37
CHART 15 SURGICAL HEART REPLACEMENT DEVICES MARKET REVENUE, BY TYPES 2017 (%) 39
TRANSCATHETER VALVES 41
CHART 16 TRANSCATHETER VALVE REPLACEMENT DEVICES MARKET REVENUE, BY TYPES 2017 ($MILLION) 42
CHART 17 STRUCTURAL HEART DEVICES MARKET SEGMENT REVENUE BY END USERS, 2017 (%) 44
CHART 18 STRUCTURAL HEART DEVICES MARKET BY REGIONAL SEGMENTATION, 2017 (%) 48
CHART 19 STRUCTURAL HEART DEVICES MARKET REVENUE IN NORTH AMERICA, 2017-2024 ($MILLION) 49
CHART 20 STRUCTURAL HEART DEVICES MARKET REVENUE IN EUROPE, 2017-2024 ($MILLION) 50
CHART 21 STRUCTURAL HEART DEVICES MARKET REVENUE IN ASIA PACIFIC, 2017-2024 ($MILLION) 53
CHART 22 STRUCTURAL HEART DEVICES REVENUE IN REST OF THE WORLD, 2017-2024 ($MILLION) 55
CHART 23 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT 59
CHART 24 ABBOTT LABORATORIES: BUSINESS UNITS 60
CHART 25 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 61
CHART 26 ABBOTT LABORATORIES: SWOT ANALYSIS 63
CHART 27 BOSTON SCIENTIFIC CORP.: OVERVIEW SNAPSHOT 65
CHART 28 BOSTON SCIENTIFIC CORP.: BUSINESS UNITS 66
CHART 29 BOSTON SCIENTIFIC CORP.: GEOGRAPHIC PRESENCE 67
CHART 30 BOSTON SCIENTIFIC CORP.: SWOT ANALYSIS 68
CHART 31 MEDTRONIC PLC: OVERVIEW SNAPSHOT 76
CHART 32 MEDTRONIC PLC: BUSINESS UNITS 78
CHART 33 MEDTRONIC PLC: GEOGRAPHIC PRESENCE 79
CHART 34 MEDTRONIC PLC: SWOT ANALYSIS 80
CHART 35 EDWARD LIFESCIENCES CORP: OVERVIEW SNAPSHOT 82
CHART 36 EDWARD LIFESCIENCES CORP: BUSINESS UNITS 83
CHART 37 EDWARD LIFESCIENCES CORP: GEOGRAPHIC PRESENCE 84
CHART 38 EDWARD LIFESCIENCES CORP: SWOT ANALYSIS 85
CHART 39 LIVANOVA: OVERVIEW SNAPSHOT 87
CHART 40 LIVANOVA PLC: BUSINESS UNITS 88
CHART 41 LIVANOVA PLC: GEOGRAPHIC PRESENCE 89
CHART 42 LIVANOVA PLC: SWOT ANALYSIS 90

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3500
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$4000
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$5000
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global Interventional Cardiology Market Research Report 2021
Global Interventional Cardiology Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-19V4307
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Cardiac Pacing Market Research Report 2021
Global Cardiac Pacing Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-30L4120
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Peripheral Vascular Devices Market Research Report 2021
Global Peripheral Vascular Devices Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-14V4329
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Venous Stents Market Research Report 2021
Global Venous Stents Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-15Q4327
Mon Feb 01 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0